Representative Andrew Garbarino Stocks
On January 14, 2022, Representative Andrew Garbarino of US Congress acquired under $15k worth of Oramed Pharmaceuticals's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are
3 other transactions of Andrew Garbarino.
View All Elective Officials Risk-return Landscape of Andrew Garbarino's positions
Assets Rated by Market Efficiency
Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the
Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions
here.